Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.0577249575551784 -0.0747028862478778 -0.0747028862478778 -0.0747028862478778
Stock impact report

ImmuCell reports preliminary Q1 sales, stock climbs 7% [Seeking Alpha]

ImmuCell Corporation (ICCC) 
US:NASDAQ Investor Relations: immucell.com/investors
Company Research Source: Seeking Alpha
The animal health company said sales jumped 111% year-over-year to $7.3M for the quarter ended March 31, 2024. Sales for the 12-month period ended March 31 rose 33% to $21.3M, according to a statement ImmuCell also said that it expects a response from the FDA no later than May for its third submission of the Chemistry, Manufacturing and Controls Technical Section for its cow health product Re-Train. Recommended For You More Trending News Recommended For You More Trending News About ICCC Stock Related Stocks Trending Analysis Trending News Show less Read more
Impact Snapshot
Event Time:
ICCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ICCC alerts
Opt-in for
ICCC alerts

from News Quantified
Opt-in for
ICCC alerts

from News Quantified